Key Highlights

  • Intel sold 210,526,315 shares at $95 apiece, upsizing the offering from an initial $15 billion to $20 billion after order Demand reportedly reached roughly $100 billion.
  • Net proceeds of about $19.7 billion are earmarked for general corporate purposes, including capital expenditures, as the company funds a 2026 capital budget guided above $20 billion.
  • The raise dilutes existing shareholders by about 4.2%, a figure kept in check by a share price that has climbed roughly 164% in 2026, though the stock remains about 30% below its June peak.
  • Underwriters hold a 30-day option on a further 31,578,947 shares that could push gross proceeds toward $23 billion and raise dilution to roughly 4.8% if fully exercised.

An Offering That Grew Quickly

Intel's (NASDAQ:INTC) share sale started smaller than it finished. Monday morning's announcement pointed to $15 billion; by the time the books closed that evening, the company had upsized the deal to $20 billion and priced 210,526,315 shares at $95 each, a 2.6% discount to Monday's $97.52 close. Net proceeds come to about $19.7 billion, with settlement due on 12 August. Underwriters also hold a 30-day option over a further 31,578,947 shares, worth roughly $3 billion at the Offer Price and capable of pushing gross proceeds toward $23 billion. That option was originally sized at $2.25 billion in the preliminary prospectus filed with securities regulators; it scaled up along with the deal.

The reason for the upsize was straightforward: reported order demand reached around $100 billion, roughly five times the eventual deal size, which is a stronger reception than a chipmaker working through a turnaround typically gets when it asks the market for capital. J.P. Morgan, Goldman Sachs, Morgan Stanley and Citigroup ran the books.

Intel's own language about where the cash goes is deliberately broad: general corporate purposes, which may include capital expenditures and working capital, without naming a specific fab or process node. The company has guided to more than $20 billion of capital spending in 2026 and expects 2027 to be higher again, so this single raise covers close to a full year of building.

Why the Share Price Barely Moved

The initial $15 billion plan knocked the stock down 4.06% on Monday. Tuesday was calmer: shares traded between $95.35 and $98.35 and closed at $97.71, up 0.19%, comfortably above the $95 clearing price on Volume of well over 90 million shares. Market Capitalization stands at roughly $513 billion.

That resilience is central to the timing. Intel is up around 164% in 2026, ahead of other major chipmakers over the same stretch. At last August's government Investment price of $20.47 a share, raising $15 billion would have required something like 733 million new shares; at $95, it takes 210 million. The rally has done the heavy lifting on dilution, which lands at about 4.2% against the 5,043 million shares outstanding at the end of June, rising to roughly 4.8% if the underwriters' option is fully exercised.

The counterweight is that the shares are still around 30% below their June peak, when the company briefly carried a $673 billion valuation. Anyone who bought near that top is now being diluted on top of an existing drawdown.

The Quarter That Made the Raise Possible

Second-quarter results reported on 23 July were the company's best top-line print in more than fifteen years: Revenue of $16.1 billion, up 25%, with Data Center and AI revenue surging 59% to $6.3 billion and the foundry Business up 31% to $5.8 billion. GAAP gross Margin improved 12.9 percentage points to 40.4%. Non-GAAP Earnings came in at $0.42 a share on Net Income of $2.2 billion.

The headline number underneath was less flattering: a GAAP net loss of $11.0 billion, or $(2.16) a share. Most of it traces to a $12.5 billion mark-to-market loss on shares held In Escrow for the U.S. government under last year's CHIPS agreement, an accounting charge that grows larger the more the stock rises. Chief executive Lip-Bu Tan framed the quarter around demand, saying AI is driving unprecedented demand for compute and that Intel is well positioned to capture sustainable growth.

The foundry division remains the drag, losing $2.1 billion at the operating line, an improvement from a $3.2 billion loss a year earlier. The Balance Sheet had also thinned, with $29.7 billion of cash and short-term investments against $48.5 billion of Debt at the end of June, after the company spent $14.2 billion in April buying out a partner's 49% interest in its Irish fab venture. Against a capital program north of $20 billion a year, the Equity raise reads less as a flourish than as a necessity.

The 14A Question Still Unanswered

Intel's 18A process is now in volume production at its Arizona fab and underpins the current Panther Lake client platform, with an 18A-P variant following. The more consequential commercial argument, though, rests on 14A, the node the company needs external customers to fill. It is targeted for high-volume Manufacturing around 2028 and requires extreme ultraviolet lithography machines priced at roughly $400 million apiece.

Progress there is real but still thin. Tesla signed on in April as the first major external 14A customer for its Terafab program, with SpaceX also lined up to use the node. Apple was reported in May to be in early talks about U.S. capacity, and Google and Amazon have been linked to Intel's packaging and manufacturing services. None of that amounts to a signed volume commitment yet. Tan has said customers will make firm supplier decisions from the second half of 2026 into the first half of 2027, and Intel plans to ship the 14A design kit in October, the release most prospective customers need before committing.

Investor Dan Niles read the upsize as a signal, arguing the company is close to signing up one or more major foundry customers and that the offering increased his conviction it is on a path chief financial officer David Zinsner has described as “super successful.” That view is an inference from the deal's size rather than a disclosed fact.

What Could Still Go Wrong

The competitive gap has not closed. A leading rival foundry lifted its own 2026 capital budget by about 15% in July, to $60 billion to $64 billion, funded from Operating Cash Flow rather than the equity market. Intel is spending roughly a third of that while carrying a loss-making foundry and a Shareholder register that includes the U.S. government at roughly 10%, alongside sizable stakes from Nvidia and SoftBank, plus warrants over 241 million shares at $20 that would trigger if Intel's stake in its own foundry business ever fell below 51%. Sell-Side sentiment sits closer to hold than buy relative to the current share price, with an average price target near $115.

The raise buys roughly a year of runway and removes any immediate funding concern. What it cannot buy is a customer signature on 14A. If the design kit lands in October and firm commitments follow this winter, the $95 offer price will likely look cheap in hindsight. If the second half of the year passes with talks but no signed agreements, the company will have spent $20 billion of shareholder capital tooling a fab for demand that has yet to show up in writing.

Conclusion

Intel's upsized $20 billion offering reflects strong near-term demand for its shares and buys the company roughly a year of funding for its capital-intensive foundry buildout, at a dilution cost investors appear willing to absorb given the stock's 2026 rally. The raise addresses a funding question, not a customer question. Whether 14A attracts binding commitments once the design kit ships in October remains the unresolved variable that will determine whether this capital was well spent.